{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:31:40Z","timestamp":1740119500435,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejps.2024.106975","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:34:14Z","timestamp":1733157254000},"page":"106975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Developing a method for the study of perfusion effects in topical product pharmacokinetics"],"prefix":"10.1016","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6505-7532","authenticated-orcid":false,"given":"Saara K.","family":"Luna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1906-2829","authenticated-orcid":false,"given":"M. Alice","family":"Maciel Tabosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-4653","authenticated-orcid":false,"given":"Ting Chean","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2185-6505","authenticated-orcid":false,"given":"Conor L.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106975_b1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00128071-200304070-00004","article-title":"Topical acne drugs: review of clinical properties, systemic exposure, and safety","volume":"4","author":"Akhavan","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"year":"2017","series-title":"NonCompart: Noncompartmental analysis for pharmacokinetic data. R package version 0.2. 6","author":"Bae","key":"10.1016\/j.ejps.2024.106975_b2"},{"issue":"27","key":"10.1016\/j.ejps.2024.106975_b3","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.2174\/092986712803306358","article-title":"Transdermal drug delivery in vitro using diffusion cells","volume":"19","author":"Bartosova","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106975_b4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2023.10.026","article-title":"Visualisation of drug distribution in skin using correlative optical spectroscopy and mass spectrometry imaging","volume":"364","author":"Belsey","year":"2023","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ejps.2024.106975_b5","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3390\/pharmaceutics15082165","article-title":"Advance and challenges in the treatment of skin diseases with the transdermal drug delivery system","volume":"15","author":"Cheng","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2024.106975_b6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1007496","article-title":"A mechanistic physiologically based model to assess the effect of study design and modified physiology on formulation safe space for virtual bioequivalence of dermatological drug products","volume":"13","author":"Clarke","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2024.106975_b7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jid.2020.06.027","article-title":"Label-free quantification of pharmacokinetics in skin with stimulated Raman scattering microscopy and deep learning","volume":"141","author":"Feizpour","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.ejps.2024.106975_b8","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.3390\/molecules161210507","article-title":"Transdermal drug delivery enhancement by compounds of natural origin","volume":"16","author":"Fox","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2024.106975_b9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.addr.2019.11.004","article-title":"Imaging and quantifying drug delivery in skin\u2013part 1: Autoradiography and mass spectrometry imaging","volume":"153","author":"Gr\u00e9goire","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ejps.2024.106975_b10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejpb.2004.03.002","article-title":"Skin deep","volume":"58","author":"Hadgraft","year":"2004","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"issue":"9081","key":"10.1016\/j.ejps.2024.106975_b11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0140-6736(05)62032-6","article-title":"Systemic absorption of sunscreen after topical application","volume":"350","author":"Hayden","year":"1997","journal-title":"The Lancet"},{"key":"10.1016\/j.ejps.2024.106975_b12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11095-007-9429-7","article-title":"In vivo methods for the assessment of topical drug bioavailability","volume":"25","author":"Herkenne","year":"2008","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.ejps.2024.106975_b13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jconrel.2024.02.010","article-title":"Determining topical product bioequivalence with stimulated Raman scattering microscopy","volume":"367","author":"Iliopoulos","year":"2024","journal-title":"J. Control. Release"},{"issue":"177","key":"10.1016\/j.ejps.2024.106975_b14","doi-asserted-by":"crossref","DOI":"10.3791\/63264-v","article-title":"Visualizing and quantifying pharmaceutical compounds within skin using coherent Raman scattering imaging","author":"Kuzma","year":"2021","journal-title":"J. Vis. Exp.: JoVE"},{"key":"10.1016\/j.ejps.2024.106975_b15","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100151","article-title":"Instantaneous topical drug quantification using a 3D printed microfluidic device and coherent Raman imaging","volume":"12","author":"Kuzma","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.ejps.2024.106975_b16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13346-020-00864-8","article-title":"Predicting topical drug clearance from the skin","volume":"11","author":"Maciel Tabosa","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"6","key":"10.1016\/j.ejps.2024.106975_b17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/10717540500466089","article-title":"Evaluation of ex vivo human skin permeation of genistein and daidzein","volume":"13","author":"Minghetti","year":"2006","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2024.106975_b18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124012","article-title":"In vitro studies into establishing therapeutic bioequivalence of complex topical products: Weight of evidence","volume":"656","author":"Miranda","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejps.2024.106975_b19","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1208\/s12249-010-9522-9","article-title":"Validation of a static franz diffusion cell system for in vitro permeation studies","volume":"11","author":"Ng","year":"2010","journal-title":"Aaps Pharmscitech"},{"issue":"8","key":"10.1016\/j.ejps.2024.106975_b20","first-page":"1060","article-title":"Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin","volume":"11","author":"Patel","year":"2022","journal-title":"CPT: Pharmacomet. Syst. Pharmacol."},{"issue":"22","key":"10.1016\/j.ejps.2024.106975_b21","doi-asserted-by":"crossref","first-page":"19145","DOI":"10.1021\/acsomega.2c08016","article-title":"New insights in topical drug delivery for skin disorders: from a nanotechnological perspective","volume":"8","author":"Raina","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejps.2024.106975_b22","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113929","article-title":"Topical drug delivery: History, percutaneous absorption, and product development","volume":"177","author":"Roberts","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6009","key":"10.1016\/j.ejps.2024.106975_b23","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1126\/science.1197236","article-title":"Video-rate molecular imaging in vivo with stimulated Raman scattering","volume":"330","author":"Saar","year":"2010","journal-title":"science"},{"issue":"3","key":"10.1016\/j.ejps.2024.106975_b24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/pharmaceutics10030148","article-title":"Franz diffusion cell approach for pre-formulation characterisation of ketoprofen semi-solid dosage forms","volume":"10","author":"Salamanca","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2024.106975_b25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121469","article-title":"Skin pharmacokinetics of diclofenac and co-delivered functional excipients","volume":"614","author":"Tabosa","year":"2022","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724002884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724002884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T15:20:09Z","timestamp":1736608809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724002884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":25,"alternative-id":["S0928098724002884"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106975","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing a method for the study of perfusion effects in topical product pharmacokinetics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106975"}}